Related Experiment Video
Updated: Jun 8, 2026
08:22
Assessing Cytotoxicity of Metabolites of Typical Triazole Pesticides in Plants
Published on: December 22, 2023
Alkyllead compounds and their environmental toxicology
1Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Atlanta, GA 30333, USA.
Metal Ions in Life Sciences
|September 30, 2010
Summary
Alkyllead compounds, like tetraethyllead, were major sources of lead pollution from gasoline. Their decline due to phasing out leaded gasoline represents a significant public health success, reducing neurotoxicity risks.
Area of Science:
- Environmental Chemistry
- Toxicology
- Public Health
Background:
- Alkyllead compounds, such as tetraethyllead and tetramethyllead, were widely used as gasoline additives.
- Auto emissions from leaded gasoline significantly contributed to environmental lead pollution.
- Alkyllead compounds are readily absorbed by living organisms and can cross the blood-brain barrier due to their lipid solubility.
Purpose of the Study:
- To review the toxicokinetics of organic lead compounds.
- To highlight the role of alkyllead compounds in environmental lead pollution.
- To discuss the public health impact and successful reduction of alkyllead usage.
Main Methods:
- Review of toxicokinetic data for organic lead compounds.
- Analysis of the historical use of alkyllead compounds as gasoline additives.
- Examination of the environmental and health impacts of alkyllead exposure.
Main Results:
- Alkyllead compounds are more toxic than inorganic lead, with neurotoxicity being a primary effect.
- Environmental pollution by lead was largely driven by auto emissions from alkyllead additives.
- Toxicokinetic information serves as a biomarker for monitoring exposure to organic lead.
Conclusions:
- The global phase-out of leaded gasoline has led to a significant decline in alkyllead compound usage.
- This reduction in alkyllead exposure is a major public health achievement, mitigating widespread neurotoxicity.
- Continued monitoring and understanding of lead toxicokinetics remain important for public health protection.
Related Concept Videos
01:36Types of Toxins
Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
01:26Toxic Reactions: Overview
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
01:23Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:27Effects of Chemicals: Overview
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
01:25Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...